NMT for Parkinson's Disease
Neurologic Music Therapy for Enhancing Fine Motor Control in Parkinson's Disease
2 other identifiers
interventional
100
1 country
1
Brief Summary
Parkinson's Disease (PD) is defined by characteristic motor symptoms including slow movements, small movements, difficulty with movement initiation and disruptions in timing. Besides gross motor symptoms, fine motor impairments in PD cause difficulties with everyday tasks such as writing, self-care, and fine object manipulation. These activity limitations can lead to disability, social isolation, and a reduced quality of life. In a series of breakthrough studies Michael Thaut and colleagues developed Neurologic Music Therapy (NMT) and found it can address many gross motor impairments and improve gait and balance. Other music therapies such as Music-supported Therapy (MST) have proven motor benefits in stroke patients through movement exercises with musical instruments. However, the pathological basal ganglia (BG) in PD brains leads to a reduced supply of those internally generated movements. In contrast, externally cued movements (eg. via a beat or a rhythm) during NMT sessions are instantaneously entrained to the period of a rhythmic stimulus possibly without involvement of the BG. The underlying idea is that rhythm is the essential component relating music specifically to motor behavior. The mechanism of action is called "rhythmic entrainment" where one system's motion or signal frequency entrains the frequency of another system. The effect of NMT on fine motor function has not been investigated yet. Music activities are important in the lives of many older adults. Notably, the use of music has been associated with increased well-being for older adults, as it fosters social connection and mood regulation. Furthermore, many musical activities have limited physical demands, making them attainable for individuals who are living with mobility impairments or other physical restrictions. Based on the literature and the investigators preliminary studies, the investigators propose to test the efficacy of Neurologic Music Therapy in comparison to Music Supported Therapy and Occupational Therapy (OT) as standard of care on adults in the Parkinson's spectrum. The investigators have defined a working plan using different musical instruments and growing tempo to specifically improve fine motor movements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable parkinson-disease
Started Apr 2017
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2017
CompletedFirst Posted
Study publicly available on registry
February 9, 2017
CompletedStudy Start
First participant enrolled
April 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedJanuary 3, 2024
January 1, 2024
7.7 years
February 2, 2017
January 2, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Clinical Outcome: Motor 1 (change in the Grooved Pegboard Test)
First motor outcome will be a change in the Grooved Pegboard Test.
Baseline and 5 weeks
Quality of Life (QOL) Outcome: QOL 1 (change in the 39-Item Parkinson's Disease)
First QOL outcome will be a change in the 39-Item Parkinson's Disease Questionnaire.
Baseline and 5 weeks
Mechanistic Outcome: Neurophysiology 1 (change in motor beta and gamma power using Magnetoencephalography)
Our first mechanistic outcome will be a change in cortical motor beta and gamma power using Magnetoencephalography.
Baseline and 5 weeks
Mechanistic Outcome: Neurophysiology 2 (change in auditory-motor functional connectivity using Magnetoencephalography)
Our second neurophysiology outcome will be a change in auditory-motor functional connectivity using Magnetoencephalography
Baseline and 5 weeks
Secondary Outcomes (4)
Clinical Outcome: Motor 2 (change in the Unified Parkinson Disease Rating Scale Part III)
Baseline and 5 weeks
Clinical Outcome: Motor 3 (change in the Finger-Thumb opposition from the Neurological Evaluation Scale)
Baseline and 5 weeks
Quality of Life (QOL) Outcome: QOL 2 (change in the Clinical Global Impression - Improvement Scale)
Baseline and 5 weeks
Quality of Life (QOL) Outcome: QOL 3 (change in the Hospital Anxiety and Depression Scale)
Baseline and 5 weeks
Study Arms (4)
Neurologic Music Therapy (NMT)
EXPERIMENTALNeurologic Music Therapy is a 5-week intervention using different musical instruments and auditory cues to specifically improve fine motor movements.
Occupational Therapy (OT)
ACTIVE COMPARATORStandard of care occupational therapy uses traditional motor training.
Waitlist Control
NO INTERVENTIONParticipants assigned to the waitlist-control condition will not immediately receive services. The no-treatment duration for these participants is yoked to the amount of time their respective NMT- and OT-condition participants receive services (5 weeks). After the wait period, these participants will then be randomized to receive either NMT, MST or OT sessions.
Music Supported Therapy (MST)
ACTIVE COMPARATORMusic Supported Therapy uses musical instruments to train fine motor movements.
Interventions
Neurologic Music Therapy uses rhythms to change brain activity and function.
Occupational Therapy uses traditional motor training.
Music Supported Therapy uses musical instruments to train fine motor movements.
Eligibility Criteria
You may qualify if:
- Age 45 to 85
- Diagnosis of Parkinson's Disease using the UK Brain Bank Criteria
- Fine motor impairments (if available, scores 2 and higher on the UPDRS motor examination part III.23 and 24)
- Medication stable for at least 30 days.
You may not qualify if:
- Features suggestive of other causes of parkinsonism, including cerebrovascular disease or history of major head trauma
- Inability to move fingers or hands
- Hoehn and Yahr stage 4 and higher
- Ferrous metal implants which may interfere with the MEG data acquisition and/or be an MRI safety concern
- Dementia
- Participants engaged in other research studies involving music therapies
- Participants whose insurance does not cover Occupational Therapy costs or who have no insurance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Colorado Denver
Aurora, Colorado, 80045, United States
Related Publications (1)
Buard I, Lattanzio L, Stewart R, Thompson S, Sjoberg K, Hookstadt K, Morrow M, Holden SK, Sillau S, Thaut M, Kluger B. Randomized controlled trial of neurologic music therapy in Parkinson's disease: research rehabilitation protocols for mechanistic and clinical investigations. Trials. 2021 Aug 28;22(1):577. doi: 10.1186/s13063-021-05560-7.
PMID: 34454592DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Isabelle Buard, PhD
University of Colorado, Denver
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2017
First Posted
February 9, 2017
Study Start
April 26, 2017
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
January 3, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
De-identified data will be made available to the scientific community upon request. Data sharing will include motor tests, questionnaires and MEG raw data.